BETA BIONICS INC (BBNX:NASDAQ)
$19.72 0.18 (0.9212%)
Analysed BETA BIONICS INC (BBNX:NASDAQ) News Sources
Beta Bionics, Inc. Q1 2026 Earnings Call Summary
22-04-2026
moby.co
Beta Bionics to Present at the Bank of America Securities Health Care Conference
27-04-2026
yahoo.com
Here's Why We're Not Too Worried About Beta Bionics' (NASDAQ:BBNX) Cash Burn Situation
12-05-2026
yahoo.com
Beta Bionics Touts Pharmacy Push, iLet Momentum and 2027 Mint Patch Pump Plans
13-05-2026
marketbeat.com
Beta Bionics Updates Commercialization Timeline Expectations for Mint™, its Patch Pump in Development
21-05-2026
yahoo.com
Beta Bionics to launch its first insulin patch pump to compete with Insulet
26-05-2026
medtechdive.com
Beta Bionics First in Automated Insulin Delivery to Publish Near Real-Time Real-World Data on a Public Website
02-06-2026
yahoo.com
Beta Bionics to Announce Second Quarter 2026 Financial Results on July 29, 2026
01-07-2026
yahoo.com
Beta Bionics (BBNX) Stock Fair Value Falls As Medtech Reset Tempers iLet And Mint Optimism
25-07-2026
yahoo.com
Beta Bionics (BBNX) Q2 2026 Earnings Call Transcript
08-08-2026
fool.com
What is the current price of BETA BIONICS INC (BBNX:NASDAQ)?
The current price of BETA BIONICS INC (BBNX:NASDAQ) is $19.72.
BETA BIONICS INC (BBNX:NASDAQ) absolute price change since previous trading day?
The absolute price change of BETA BIONICS INC (BBNX:NASDAQ) since the previous trading day is $0.18.
BETA BIONICS INC (BBNX:NASDAQ) percentage price change since previous trading day?
The percentage price change of BETA BIONICS INC (BBNX:NASDAQ) since the previous trading day is 0.9212%.
What is the most recent average sentiment score for BETA BIONICS INC (BBNX:NASDAQ)?
The most recent average sentiment score for BETA BIONICS INC (BBNX:NASDAQ) is 72 out of 100.
What is the most recent average sentiment for BETA BIONICS INC (BBNX:NASDAQ)?
The most recent sentiment for BETA BIONICS INC (BBNX:NASDAQ) is .
SEC-8K** Filing Available For BETA BIONICS INC (BBNX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.